Gufic Biosciences Ltd (BOM:509079)
₹ 452.15 -3.1 (-0.68%) Market Cap: 45.34 Bil Enterprise Value: 48.66 Bil PE Ratio: 52.03 PB Ratio: 8.51 GF Score: 92/100

Q3 2023 Gufic Biosciences Ltd Earnings Call Transcript

Feb 20, 2023 / 11:00AM GMT
Release Date Price: ₹212.4 (+2.41%)
Operator

Ladies and gentlemen, good day, and welcome to the Q3 FY 2022-23 earnings conference call of Gufic Biosciences Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Ami Shah, Company Secretary.

Thank you, and over to you, Ma'am.

Ami Shah
Gufic Biosciences Limited - Company Secretary & Compliance Officer

Thank you. Good evening and a warm welcome to Gufic Biosciences Limited earnings conference call for the third quarter of financial year '22, '23. I have with me, Mr. Pranav Choksi, Chief Executive Officer and Whole-Time Director; Mr. Devkinandan Roonghta, Chief Financial Officer; and Mr. Avik Das from Investor Relations team to give the highlights of the business performance of the company and to clarify all the questions of investors during the call.

We will begin the call with the business highlights and overview by Mr. Avik, followed by financial overview by Mr. Roonghta. After the opening remarks, the operator will open the bridge for Q&A session. But before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot